Pubblicazioni

1 AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES–2016 UPDATE.

Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, Paschke R, Valcavi R, Vitti P; AACE/ACE/AME Task Force on Thyroid Nodules.
Endocr Pract. 2016 May;22(5):622-39. doi: 10.4158/EP161208.GL.
PMID: 27167915

2 Sonography of Normal and Abnormal Thyroid and Parathyroid Glands.

Andrioli M, Valcavi R.
Front Horm Res. 2016;45:1-15. doi: 10.1159/000442273. Epub 2016 Mar 15.
PMID: 27002829Review.

3 Thermal ablation for benign thyroid nodules: radiofrequency and laser.

Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG.
Korean J Radiol. 2011 Sep-Oct;12(5):525-40. doi: 10.3348/kjr.2011.12.5.525. Epub 2011 Aug 24.
PMID: 21927553Free PMC article.Review.

4 Thyroid hormones and growth hormone secretion.

Valcavi R, Zini M, Portioli I.
J Endocrinol Invest. 1992 Apr;15(4):313-30. doi: 10.1007/BF03348744.
PMID: 1512425Review.No abstract available.

5 Thyroid nodule guidelines: agreement, disagreement and need for future research.

Paschke R, Hegedüs L, Alexander E, Valcavi R, Papini E, Gharib H.
Nat Rev Endocrinol. 2011 Jun;7(6):354-61. doi: 10.1038/nrendo.2011.1. Epub 2011 Mar 1.
PMID: 21364517Review.

6 Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature.

Giordano D, Valcavi R, Thompson GB, Pedroni C, Renna L, Gradoni P, Barbieri V.
Thyroid. 2012 Sep;22(9):911-7. doi: 10.1089/thy.2012.0011. Epub 2012 Jul 24.
PMID: 22827494Review.

7 Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement.

Garberoglio R, Aliberti C, Appetecchia M, Attard M, Boccuzzi G, Boraso F, Borretta G, Caruso G, Deandrea M, Freddi M, Gallone G, Gandini G, Gasparri G, Gazzera C, Ghigo E, Grosso M, Limone P, Maccario M, Mansi L, Mormile A, Nasi PG, Orlandi F, Pacchioni D, Pacella CM, Palestini N, Papini E, Pelizzo MR, Piotto A, Rago T, Riganti F, Rosato L, Rossetto R, Scarmozzino A, Spiezia S, Testori O, Valcavi R, Veltri A, Vitti P, Zingrillo M.
J Ultrasound. 2015 Jun 19;18(4):423-30. doi: 10.1007/s40477-015-0169-y. eCollection 2015 Dec.
PMID: 26550079Free PMC article.No abstract available.

8 Ultrasound thyroid nodule measurements: the “gold standard” and its limitations in clinical decision making.

Gallo M, Pesenti M, Valcavi R.
Endocr Pract. 2003 May-Jun;9(3):194-9. doi: 10.4158/EP.9.3.194.
PMID: 12917060Review.

9 HEALTH-RELATED QUALITY OF LIFE AFTER PERCUTANEOUS RADIOFREQUENCY ABLATION OF COLD, SOLID, BENIGN THYROID NODULES: A 2-YEAR FOLLOW-UP STUDY IN 40 PATIENTS.

Valcavi R, Tsamatropoulos P.
Endocr Pract. 2015 Aug;21(8):887-96. doi: 10.4158/EP15676.OR. Epub 2015 Jun 29.
PMID: 26121459

10 [Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: description of a case].

Cavazza A, Toschi E, Valcavi R, Piana S, Scotti R, Carlinfante G, Gardini G.
Pathologica. 1999 Feb;91(1):31-5.
PMID: 10396948Review.Italian.

11 Levothyroxine liquid solution versus tablet for replacement treatment in hypothyroid patients.

Negro R, Valcavi R, Agrimi D, Toulis KA.
Endocr Pract. 2014 Sep;20(9):901-6. doi: 10.4158/EP13378.OR.
PMID: 24793916

12 Ultrasound B-flow imaging in the evaluation of thermal ablation of thyroid nodules.
Andrioli M, Valcavi R.
Endocrine. 2015 Apr;48(3):1013-5. doi: 10.1007/s12020-014-0302-2. Epub 2014 Jun 1.PMID: 24880621
13 Thyrotropin values in patients with micropapillary thyroid cancer versus benign nodular disease.

Negro R, Valcavi R, Riganti F, Toulis KA, Colosimo E, Bongiovanni M, Grassi P, Giovanella L, Gardini G, Piana S.
Endocr Pract. 2013 Jul-Aug;19(4):651-5. doi: 10.4158/EP12385.OR.
PMID: 23512387

14 Detection and diagnosis of parathyroid incidentalomas during thyroid sonography.

Frasoldati A, Pesenti M, Toschi E, Azzarito C, Zini M, Valcavi R.
J Clin Ultrasound. 1999 Nov-Dec;27(9):492-8. doi: 10.1002/(sici)1097-0096(199911/12)27:9<492::aid-jcu2>3.0.co;2-h.
PMID: 10525210

15 The peculiar ultrasonographic and elastographic features of thyroid nodules after treatment with laser or radiofrequency: similarities and differences.

Andrioli M, Valcavi R.
Endocrine. 2014 Dec;47(3):967-8. doi: 10.1007/s12020-014-0241-y. Epub 2014 Mar 25.
PMID: 24664362

16 Assessing the risk of false-negative fine-needle aspiration cytology and of incidental cancer in nodular goiter.

Negro R, Piana S, Ferrari M, Ragazzi M, Gardini G, Asioli S, Pacchioni D, Riganti F, Valcavi R.
Endocr Pract. 2013 May-Jun;19(3):444-50. doi: 10.4158/EP12271.OR.
PMID: 23337148

17 A longitudinal study of thyroidectomized patients in a region of northern Italy: benign versus malignant disease.

Negro R, Gharib H, Savoldi L, Barbieri V, Valcavi R.
Endocr Pract. 2013 Mar-Apr;19(2):259-62. doi: 10.4158/EP12304.OR.
PMID: 23512384

18 Parathyroid incidentaloma discovered during thyroid ultrasound imaging.

Pesenti M, Frasoldati A, Azzarito C, Valcavi R.
J Endocrinol Invest. 1999 Nov;22(10):796-9. doi: 10.1007/BF03343646.
PMID: 10614530

19 Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial.

Papini E, Rago T, Gambelunghe G, Valcavi R, Bizzarri G, Vitti P, De Feo P, Riganti F, Misischi I, Di Stasio E, Pacella CM.
J Clin Endocrinol Metab. 2014 Oct;99(10):3653-9. doi: 10.1210/jc.2014-1826. Epub 2014 Jul 22.
PMID: 25050903Clinical Trial.

20 A Computer-Interpretable Version of the AACE, AME, ETA Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules.

Peleg M, Fox J, Patkar V, Glasspool D, Chronakis I, South M, Nassar S, Gaglia JL, Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Garber JR.
Endocr Pract. 2014 Apr;20(4):352-9. doi: 10.4158/EP13271.OR.
PMID: 24246343

21 Incidental thyroid cancer in toxic and nontoxic goiter: Is TSH associated with malignanCy rate? Results of a meta-analysis.

Negro R, Valcavi R, Toulis KA.
Endocr Pract. 2013 Mar-Apr;19(2):212-8. doi: 10.4158/EP12234.OR.
PMID: 23186976

22 Sinus node function in hyperthyroid patients.

Valcavi R, Menozzi C, Roti E, Zini M, Lolli G, Roti S, Guiducci U, Portioli I.
J Clin Endocrinol Metab. 1992 Jul;75(1):239-42. doi: 10.1210/jcem.75.1.1619016.
PMID: 1619016

23 Oral glucose tolerance test: an inhibitory or a stimulatory input to growth hormone secretion?

Valcavi R.
J Endocrinol Invest. 1996 Apr;19(4):253-5. doi: 10.1007/BF03349877.
PMID: 8862507Review.No abstract available.

24 Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: present and future perspectives.

Andrioli M, Riganti F, Pacella CM, Valcavi R.
AJR Am J Roentgenol. 2012 Nov;199(5):1164-8. doi: 10.2214/AJR.11.8442.
PMID: 23096194

25 Role of thyroglobulin measurement in fine-needle aspiration biopsies of cervical lymph nodes in patients with differentiated thyroid cancer.

Frasoldati A, Toschi E, Zini M, Flora M, Caroggio A, Dotti C, Valcavi R.
Thyroid. 1999 Feb;9(2):105-11. doi: 10.1089/thy.1999.9.105.
PMID: 10090308

26 Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation.

Valcavi R, Piana S, Bortolan GS, Lai R, Barbieri V, Negro R.
Thyroid. 2013 Dec;23(12):1578-82. doi: 10.1089/thy.2013.0279. Epub 2013 Nov 14.
PMID: 23978269

27 Pathological findings of thyroid nodules after percutaneous laser ablation : a series of 22 cases with cyto-histological correlation.

Piana S, Riganti F, Froio E, Andrioli M, Pacella CM, Valcavi R.
Endocr Pathol. 2012 Jun;23(2):94-100. doi: 10.1007/s12022-012-9192-0.
PMID: 22246921

28 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules.

Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P; AACE/AME/ETA Task Force on Thyroid Nodules.
Endocr Pract. 2010 May-Jun;16 Suppl 1:1-43. doi: 10.4158/10024.GL.
PMID: 20497938No abstract available.

29 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations.

Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P; AACE/AME/ETA Task Force on Thyroid Nodules.
J Endocrinol Invest. 2010;33(5 Suppl):51-6.
PMID: 20543551

30 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.

Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P; AACE/AME/ETA Task Force on Thyroid Nodules.
J Endocrinol Invest. 2010;33(5 Suppl):1-50.
PMID: 20543550

31 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: Executive Summary of recommendations.

Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P; AACE/AME/ETA Task Force on Thyroid Nodules.
J Endocrinol Invest. 2010 May;33(5):287-91. doi: 10.1007/BF03346587. Epub 2010 May 17.
PMID: 20479572

32 Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cells.

Ciarrocchi A, Piana S, Valcavi R, Gardini G, Casali B.
Eur J Cancer. 2011 Apr;47(6):934-45. doi: 10.1016/j.ejca.2010.11.009. Epub 2010 Dec 9.
PMID: 21146400

33 Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study.

Faggiano A, Ferolla P, Grimaldi F, Campana D, Manzoni M, Davì MV, Bianchi A, Valcavi R, Papini E, Giuffrida D, Ferone D, Fanciulli G, Arnaldi G, Franchi GM, Francia G, Fasola G, Crinò L, Pontecorvi A, Tomassetti P, Colao A.
J Endocrinol Invest. 2012 Oct;35(9):817-23. doi: 10.3275/8102. Epub 2011 Nov 9.
PMID: 22080849

34 Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group.

De Menis E, Giustina A, Colao A, Degli Uberti E, Ghigo E, Minuto F, Bogazzi F, Drigo R, Cattaneo A, Aimaretti G; COM.E.T.A. Italian Study Group.
J Endocrinol Invest. 2011 Jan;34(1):60-4. doi: 10.1007/BF03346696.
PMID: 21406941

35 Challenges in neck ultrasonography: lymphadenopathy and parathyroid glands.

Frasoldati A, Valcavi R.
Endocr Pract. 2004 May-Jun;10(3):261-8. doi: 10.4158/EP.10.3.261.
PMID: 15310545

36 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations.

Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P; AACE/AME/ETA Task Force on Thyroid Nodules.
Endocr Pract. 2010 May-Jun;16(3):468-75. doi: 10.4158/EP.16.3.468.
PMID: 20551008

37 CT cross-sectional imaging classification system for substernal goiter based on risk factors for an extracervical surgical approach.

Mercante G, Gabrielli E, Pedroni C, Formisano D, Bertolini L, Nicoli F, Valcavi R, Barbieri V.
Head Neck. 2011 Jun;33(6):792-9. doi: 10.1002/hed.21539. Epub 2010 Aug 24.
PMID: 20737483

38 Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18,000 FNAs reported at the same institution during 1998-2007.

Piana S, Frasoldati A, Ferrari M, Valcavi R, Froio E, Barbieri V, Pedroni C, Gardini G.
Cytopathology. 2011 Jun;22(3):164-73. doi: 10.1111/j.1365-2303.2010.00777.x. Epub 2010 Jul 6.
PMID: 20626438

39 Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients.

Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM.
Thyroid. 2010 Nov;20(11):1253-61. doi: 10.1089/thy.2010.0189. Epub 2010 Oct 7.
PMID: 20929405

40 Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study.

Giustina A, Mancini T, Boscani PF, de Menis E, degli Uberti E, Ghigo E, Martino E, Minuto F, Colao A; COM.E.T.A. (COMorbidities Evaluation and Treatment inAcromegaly) Italian Study Group.
J Endocrinol Invest. 2008 Aug;31(8):731-8. doi: 10.1007/BF03346423.
PMID: 18852535

41 Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.

Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, Gardini G, Valcavi R, Barbieri V.
Thyroid. 2009 Jul;19(7):707-16. doi: 10.1089/thy.2008.0270.
PMID: 19348581

42 Effect of estrogen therapy for 1 year on thyroid volume and thyroid nodules in postmenopausal women.

Ceresini G, Milli B, Morganti S, Maggio M, Bacchi-Modena A, Sgarabotto MP, Chirico C, Di Donato P, Campanati P, Valcavi R, Ceda GP, Braverman LE, Valenti G.
Menopause. 2008 Mar-Apr;15(2):326-31. doi: 10.1097/gme.0b013e318148b83e.
PMID: 17998883

43 Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules.

Valcavi R, Frasoldati A.
Endocr Pract. 2004 May-Jun;10(3):269-75. doi: 10.4158/EP.10.3.269.
PMID: 15310546Clinical Trial.

44 Influence of hyperthyroidism on growth hormone secretion.

Valcavi R, Dieguez C, Zini M, Muruais C, Casanueva F, Portioli I.
Clin Endocrinol (Oxf). 1993 May;38(5):515-22. doi: 10.1111/j.1365-2265.1993.tb00348.x.
PMID: 8330446

45 Vasoactive intestinal peptide-induced prolactin release in hypothyroid patients.

Valcavi R, Zini M, Dieguez C, Portioli I.
J Endocrinol Invest. 1993 Nov;16(10):781-5. doi: 10.1007/BF03348926.
PMID: 8144851

46 Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.

Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R.
Cancer. 2003 Jan 1;97(1):90-6. doi: 10.1002/cncr.11031.
PMID: 12491509

47 American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.

Gharib H, Papini E, Valcavi R, Baskin HJ, Crescenzi A, Dottorini ME, Duick DS, Guglielmi R, Hamilton CR Jr, Zeiger MA, Zini M; AACE/AME Task Force on Thyroid Nodules.
Endocr Pract. 2006 Jan-Feb;12(1):63-102. doi: 10.4158/EP.12.1.63.
PMID: 16596732

48 Impaired prolactin response to arginine in patients with hyperthyroidism.

Ciccarelli E, Zini M, Grottoli S, Razzore P, Portioli I, Valcavi R.
Clin Endocrinol (Oxf). 1994 Sep;41(3):371-4. doi: 10.1111/j.1365-2265.1994.tb02559.x.
PMID: 7955444

49 [Epidemiologic investigation on the prevalence of goiter and urinary excretion of iodine in the school population of the province of Reggio Emilia].

Zini M, Poluzzi V, Bertani A, Portioli I, Cavalchi B, Valcavi R.
Ann Ist Super Sanita. 1998;34(3):383-7.
PMID: 10052179Italian.

50 [Parathyroid gland surgery].

Caroggio A, Gasparri G, Sargiotto A, Serra L, Spriano G, Valcavi R.
Acta Otorhinolaryngol Ital. 2002 Feb;22(1):1-13.
PMID: 12236006Italian.No abstract available.

51 Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.

Valcavi R, Valente F, Dieguez C, Zini M, Procopio M, Portioli I, Ghigo E.
J Clin Endocrinol Metab. 1993 Sep;77(3):616-20. doi: 10.1210/jcem.77.3.8103770.
PMID: 8103770Clinical Trial.

52 Triiodothyronine administration reduces serum growth hormone levels and growth hormone responses to thyrotropin-releasing hormone in patients with anorexia nervosa.

Valcavi R, Zini M, Portioli I.
Psychoneuroendocrinology. 1990;15(4):287-95. doi: 10.1016/0306-4530(90)90079-o.
PMID: 2128417

53 Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment.

Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U, Portioli I.
J Clin Endocrinol Metab. 1995 Feb;80(2):659-66. doi: 10.1210/jcem.80.2.7852533.
PMID: 7852533Clinical Trial.

54 The late growth hormone rise induced by oral glucose is enhanced by cholinergic stimulation with pyridostigmine in normal subjects.

Valcavi R, Zini M, Davoli S, Portioli I.
Clin Endocrinol (Oxf). 1992 Oct;37(4):360-4. doi: 10.1111/j.1365-2265.1992.tb02339.x.
PMID: 1483293Clinical Trial.

55 Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.

Page MD, Dieguez C, Valcavi R, Koppeschaar HP, Scanlon MF.
Clin Endocrinol (Oxf). 1994 Jan;40(1):97-102. doi: 10.1111/j.1365-2265.1994.tb02450.x.
PMID: 8306488

56 Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins.

Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJ, Valcavi R.
J Clin Endocrinol Metab. 1993 Apr;76(4):950-5. doi: 10.1210/jcem.76.4.7682563.
PMID: 7682563

57 Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.

Miell JP, Zini M, Quin JD, Jones J, Portioli I, Valcavi R.
J Clin Endocrinol Metab. 1994 Nov;79(5):1507-12. doi: 10.1210/jcem.79.5.7525638.
PMID: 7525638

58 Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidism.

Jenkins RC, Valcavi R, Zini M, Frasoldati A, Heller SR, Camacho-Hubner C, Gibson JM, Westwood M, Ross RJ.
Clin Endocrinol (Oxf). 2000 Feb;52(2):187-95. doi: 10.1046/j.1365-2265.2000.00924.x.
PMID: 10671946Clinical Trial.

59 Effect of oral administration of melatonin on GH responses to GRF 1-44 in normal subjects.

Valcavi R, Dieguez C, Azzarito C, Edwards CA, Dotti C, Page MD, Portioli I, Scanlon MF.
Clin Endocrinol (Oxf). 1987 Apr;26(4):453-8. doi: 10.1111/j.1365-2265.1987.tb00802.x.
PMID: 3115632Clinical Trial.

60 Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.

Page MD, Dieguez C, Valcavi R, Edwards C, Hall R, Scanlon MF.
Clin Endocrinol (Oxf). 1988 May;28(5):551-8. doi: 10.1111/j.1365-2265.1988.tb03690.x.
PMID: 3145820Clinical Trial.

61 Large cell neuroendocrine carcinoma of the ampulla of vater.

Cavazza A, Gallo M, Valcavi R, De Marco L, Gardini G.
Arch Pathol Lab Med. 2003 Feb;127(2):221-3. doi: 10.1043/0003-9985(2003)127<221:LCNCOT>2.0.CO;2.
PMID: 12562240

62 Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone.

Valcavi R, Zini M, Maestroni GJ, Conti A, Portioli I.
Clin Endocrinol (Oxf). 1993 Aug;39(2):193-9. doi: 10.1111/j.1365-2265.1993.tb01773.x.
PMID: 8370132Clinical Trial.

63 [Scleroderma in patients with rectal cancer: coincidence or paraneoplastic syndrome?].

Valcavi R, Fantesini C, Portioli I.
Nouv Presse Med. 1979 Nov 26;8(46):3835.
PMID: 534256French.No abstract available.

64 [Protracted neurologic, tetanic and syncopal syndrome as a complication of idiopathic hypoparathyroidism with endocranial calcifications].

Fantesini C, Lucci B, Manicardi E, Pilastri G, Valcavi R.
Riv Neurobiol. 1982 Apr-Jun;27(2):315-20.
PMID: 7123080Italian.No abstract available.

65 Influence of thyroid status on serum immunoreactive leptin levels.

Valcavi R, Zini M, Peino R, Casanueva FF, Dieguez C.
J Clin Endocrinol Metab. 1997 May;82(5):1632-4. doi: 10.1210/jcem.82.5.3954.
PMID: 9141562

66 The influence of oestrogens on the sensitivity of PRL, TSH and LH to the inhibitory actions of dopamine in hyperprolactinaemic patients.

Valcavi R, Harris PE, Foord SM, Dieguez C, Evans PJ, Peters JR, Hall R, Scanlon MF.
Clin Endocrinol (Oxf). 1985 Aug;23(2):139-46. doi: 10.1111/j.1365-2265.1985.tb00208.x.
PMID: 4053412

67 Single oral dose of cimetidine and prolactin.

Valcavi R, Bedogni G, Dall’Asta A, Dotti C, Portioli I.
Lancet. 1978 Sep 2;2(8088):528. doi: 10.1016/s0140-6736(78)92253-5.
PMID: 79897No abstract available.

68 Effect of 15-day treatment with growth-hormone-releasing hormone alone or combined with different doses of arginine on the reduced somatotrope responsiveness to the neurohormone in normal aging.

Ghigo E, Ceda GP, Valcavi R, Goffi S, Zini M, Mucci M, Valenti G, Muller EE, Camanni F.
Eur J Endocrinol. 1995 Jan;132(1):32-6. doi: 10.1530/eje.0.1320032.
PMID: 7850007

69 Effects of oral glucose administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH release in children and adults.

Valcavi R, Zini M, Volta C, Ghizzoni L, Azzarito C, Bernasconi S, Portioli I.
J Clin Endocrinol Metab. 1994 Oct;79(4):1152-7. doi: 10.1210/jcem.79.4.7962288.
PMID: 7962288Clinical Trial.

70 Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects.

Valcavi R, Zini M.
Clin Endocrinol (Oxf). 1994 Mar;40(3):379-82.
PMID: 8187302Clinical Trial.

71 Alpha-adrenoreceptor blockade with thymoxamine reduces basal thyrotrophin levels but does not influence circadian thyrotrophin changes in man.

Valcavi R, Dieguez C, Azzarito C, Artioli C, Portioli I, Scanlon MF.
J Endocrinol. 1987 Oct;115(1):187-91. doi: 10.1677/joe.0.1150187.
PMID: 2959735

72 Effect of thyroxine replacement therapy on plasma insulin-like growth factor 1 levels and growth hormone responses to growth hormone releasing factor in hypothyroid patients.

Valcavi R, Dieguez C, Preece M, Taylor A, Portioli I, Scanlon MF.
Clin Endocrinol (Oxf). 1987 Jul;27(1):85-90. doi: 10.1111/j.1365-2265.1987.tb00842.x.
PMID: 3115637

73 Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects.

Ghigo E, Ceda GP, Valcavi R, Goffi S, Zini M, Mucci M, Valenti G, Cocchi D, Müller EE, Camanni F.
J Endocrinol Invest. 1994 Feb;17(2):113-7. doi: 10.1007/BF03347695.
PMID: 8006330Clinical Trial.

74 Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.

Arvat E, Cappa M, Casanueva FF, Dieguez C, Ghigo E, Nicolosi M, Valcavi R, Zini M.
J Clin Endocrinol Metab. 1993 Feb;76(2):374-7. doi: 10.1210/jcem.76.2.8432781.
PMID: 8432781

75 Plasma cortisol and aldosterone after ACTH 1-17: effect of different doses.

Casoli P, Valcavi R, Portioli I.
Ric Clin Lab. 1984 Apr-Jun;14(2):167-73. doi: 10.1007/BF02904969.
PMID: 6091240

76 Factitious phaeochromocytoma: a case for Sherlock Holmes.

Portioli I, Valcavi R.
Br Med J (Clin Res Ed). 1981 Dec 19-26;283(6307):1660-1. doi: 10.1136/bmj.283.6307.1660-b.
PMID: 6797600Free PMC article.No abstract available.

77 In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion.

Grottoli S, Procopio M, Maccario M, Zini M, Oleandri SE, Tassone F, Valcavi R, Ghigo E.
J Clin Endocrinol Metab. 1997 Jul;82(7):2261-5. doi: 10.1210/jcem.82.7.4093.
PMID: 9215304

78 Lack of effect of muscarinic cholinergic blockade on the GH responses to GRF 1-29 and TRH in acromegalic subjects.

Jordan V, Dieguez C, Valcavi R, Artioli C, Portioli I, Rodriguez-Arnao MD, Gomez-Pan A, Hall R, Scanlon MF.
Clin Endocrinol (Oxf). 1986 Apr;24(4):415-20. doi: 10.1111/j.1365-2265.1986.tb01646.x.
PMID: 2874906Clinical Trial.

79 Growth hormone responses to GRF 1-29 in patients with primary hypothyroidism before and during replacement therapy with thyroxine.

Valcavi R, Jordan V, Dieguez C, John R, Manicardi E, Portioli I, Rodriguez-Arnao MD, Gomez-Pan A, Hall R, Scanlon MF.
Clin Endocrinol (Oxf). 1986 Jun;24(6):693-8. doi: 10.1111/j.1365-2265.1986.tb01666.x.
PMID: 3098458

80 Effect of oral glucose on the late growth hormone rise and growth hormone responses to GHRH in normal subjects.

Valcavi R, Zini M, Dieguez C, Portioli I, Scanlon MF.
Clin Endocrinol (Oxf). 1990 May;32(5):539-43. doi: 10.1111/j.1365-2265.1990.tb00895.x.
PMID: 2114240Clinical Trial.

81 Alpha-2-adrenergic pathways release growth hormone via a non-GRF-dependent mechanism in normal human subjects.

Valcavi R, Dieguez C, Page MD, Zini M, Casoli P, Portioli I, Scanlon MF.
Clin Endocrinol (Oxf). 1988 Sep;29(3):309-16. doi: 10.1111/j.1365-2265.1988.tb01229.x.
PMID: 2855221Clinical Trial.

82 Cerebellar syndrome due to multiple ischemic lesions in hypothyroidism.

Guidetti D, Greco G, Zucco R, Manicardi E, Valcavi R.
Ital J Neurol Sci. 1990 Apr;11(2):183-4. doi: 10.1007/BF02335563.
PMID: 2361855No abstract available.

83 Effect of pyridostigmine and pirenzepine on GH responses to GHRH in hyperthyroid patients.

Valcavi R, Dieguez C, Zini M, Page MD, Dotti C, Portioli I, Scanlon MF.
Clin Endocrinol (Oxf). 1991 Aug;35(2):141-4. doi: 10.1111/j.1365-2265.1991.tb03512.x.
PMID: 1934529

84 [Hypokalemic periodic paralysis. Clinical case and etiopathogenetic considerations].

Lucci B, Valcavi R, Fantesini C, Motti L, Portioli I.
Riv Neurobiol. 1982 Apr-Jun;27(2):296-302.
PMID: 7123078 Italian. No abstract available.

 

Pubblicazioni consultabili

Libri acquistabili e DVD

Libro
Dvd

 

CONTATTO DIRETTO CON E.T.C. CLINIC
INVIA
ItalianEnglish